Traders Buy High Volume of Call Options on Cibus (NASDAQ:CBUS)

Cibus, Inc. (NASDAQ:CBUS) was the recipient of some unusual options trading on Tuesday. Traders bought 6,983 call options on the stock. This is an increase of 7,409% compared to the typical volume of 93 call options.

Cibus Stock Performance

Shares of NASDAQ CBUS traded up $0.44 during midday trading on Tuesday, reaching $2.74. 750,744 shares of the stock were exchanged, compared to its average volume of 380,926. The stock has a market capitalization of $148.73 million, a P/E ratio of -0.84 and a beta of 1.80. The company has a 50 day simple moving average of $1.87 and a 200 day simple moving average of $1.57. Cibus has a twelve month low of $1.09 and a twelve month high of $3.40.

Analyst Ratings Changes

A number of equities research analysts have recently commented on CBUS shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Cibus in a research report on Wednesday, January 21st. Canaccord Genuity Group reaffirmed a “buy” rating and set a $15.00 price objective on shares of Cibus in a research note on Monday, December 8th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cibus presently has a consensus rating of “Hold” and an average price target of $20.00.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CBUS. Bank of America Corp DE increased its holdings in Cibus by 113.4% during the 4th quarter. Bank of America Corp DE now owns 35,536 shares of the company’s stock worth $99,000 after purchasing an additional 18,885 shares during the period. AQR Capital Management LLC purchased a new stake in shares of Cibus during the first quarter worth approximately $73,000. FNY Investment Advisers LLC acquired a new stake in Cibus in the second quarter valued at approximately $54,000. Warberg Asset Management LLC purchased a new position in Cibus in the second quarter worth approximately $41,000. Finally, Transce3nd LLC lifted its stake in Cibus by 29.1% in the second quarter. Transce3nd LLC now owns 52,656 shares of the company’s stock worth $75,000 after acquiring an additional 11,861 shares during the last quarter. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Cibus Company Profile

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.